in clinical studies of patients with ovarian cancer who received in vivo immunotherapy with either iodine-131 ( not aggregated ) or yttrium-90 ( aggregated ) hmfg1 mouse monoclonal antibody , no significant difference was found between the immune responses to aggregated and non-aggregated murine immunoglobulin g .
C0301872
immune responses
C0020852
immunoglobulin g